• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解决美国肝癌护理中的种族和民族差异。

Addressing racial and ethnic disparities in US liver cancer care.

机构信息

Division of Gastroenterology, Department of Medicine, University of Washington, Seattle, Washington, USA.

Department of Medicine, University of Washington, Seattle, Washington, USA.

出版信息

Hepatol Commun. 2023 Jun 22;7(7). doi: 10.1097/HC9.0000000000000190. eCollection 2023 Jul 1.

DOI:10.1097/HC9.0000000000000190
PMID:37347221
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10289716/
Abstract

HCC, the most common form of primary liver cancer, is the fastest rising cause of cancer-related death in the United States. HCC disproportionately affects racial and ethnic minorities in the United States. A practical framework is needed to organize the complex patient, provider, health system, and societal factors that drive these racial and ethnic disparities. In this narrative review, we adapted and applied the National Institute on Minority Health and Health Disparities (NIMHD) Research Framework to the HCC care continuum, as a step toward better understanding and addressing existing HCC-related disparities. We first summarize the literature on HCC-related disparities by race and ethnicity organized by the framework's 5 domains (biological, behavioral, physical/built environment, sociocultural environment, and health care system) and 4 levels (individual, interpersonal, community, and societal) of influence. We then offer strategies to guide future research initiatives toward promotion of health equity in HCC care. Clinicians and researchers may help mitigate further inequities and better address racial and ethnic disparities in HCC care by prioritizing the following in HCC research: (1) increasing racial and ethnic minority representation, (2) collecting and reporting HCC-related data by racial and ethnic subgroups, (3) assessing the patient experience of HCC care by race and ethnicity, and (4) evaluating HCC-specific social determinants of health by race and ethnicity. These 4 priorities will help inform the development of future programs and interventions that are tailored to the unique experiences of each racial and ethnic group.

摘要

HCC 是原发性肝癌最常见的形式,也是美国癌症相关死亡人数增长最快的原因。HCC 在美国不成比例地影响着少数族裔。需要一个实用的框架来组织复杂的患者、提供者、医疗保健系统和社会因素,这些因素推动了这些种族和族裔差异。在这篇叙述性评论中,我们改编并应用了国家少数民族健康与健康差异研究所(NIMHD)的研究框架,将其应用于 HCC 护理连续体,以更好地理解和解决现有的 HCC 相关差异。我们首先按照框架的 5 个领域(生物、行为、物理/建筑环境、社会文化环境和医疗保健系统)和 4 个影响层次(个人、人际、社区和社会)总结了按种族和族裔组织的 HCC 相关差异文献。然后,我们提供了策略来指导未来的研究计划,以促进 HCC 护理中的健康公平。临床医生和研究人员可以通过以下方式帮助减轻 HCC 护理中的进一步不平等,并更好地解决种族和族裔差异:(1)增加少数族裔的代表性;(2)按种族和族裔亚组收集和报告 HCC 相关数据;(3)评估种族和族裔对 HCC 护理的患者体验;(4)按种族和族裔评估 HCC 特定的健康社会决定因素。这 4 个优先事项将有助于为未来的计划和干预措施的制定提供信息,这些计划和干预措施针对每个种族和族裔的独特经验进行了定制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ea/10289716/00382e229af7/hc9-7-e00190-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ea/10289716/058c5b1ff435/hc9-7-e00190-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ea/10289716/00382e229af7/hc9-7-e00190-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ea/10289716/058c5b1ff435/hc9-7-e00190-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ea/10289716/00382e229af7/hc9-7-e00190-g003.jpg

相似文献

1
Addressing racial and ethnic disparities in US liver cancer care.解决美国肝癌护理中的种族和民族差异。
Hepatol Commun. 2023 Jun 22;7(7). doi: 10.1097/HC9.0000000000000190. eCollection 2023 Jul 1.
2
Racial and Ethnic Disparities in Barriers to Care in Patients with Hepatocellular Carcinoma.肝细胞癌患者护理障碍中的种族和民族差异。
Clin Gastroenterol Hepatol. 2023 Apr;21(4):1094-1096.e2. doi: 10.1016/j.cgh.2021.12.027. Epub 2021 Dec 26.
3
Burden of liver cancer mortality by county, race, and ethnicity in the USA, 2000-19: a systematic analysis of health disparities.美国 2000-19 年按县、种族和族裔划分的肝癌死亡率负担:健康差距的系统分析。
Lancet Public Health. 2024 Mar;9(3):e186-e198. doi: 10.1016/S2468-2667(24)00002-1.
4
Racial and Ethnic Disparities in Hepatocellular Carcinoma Treatment Receipt in the United States: A Systematic Review and Meta-Analysis.美国肝细胞癌治疗中种族和民族差异的系统评价和荟萃分析。
Cancer Epidemiol Biomarkers Prev. 2024 Apr 3;33(4):463-470. doi: 10.1158/1055-9965.EPI-23-1236.
5
Racial and Ethnic Disparities in Survival Among Patients With Hepatocellular Carcinoma in the United States: A Systematic Review and Meta-Analysis.美国肝细胞癌患者生存中的种族和民族差异:系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2022 Feb;20(2):e267-e288. doi: 10.1016/j.cgh.2020.12.029. Epub 2020 Dec 30.
6
The Institute of Medicine report "Unequal Treatment": implications for academic health centers.医学研究所报告《不平等待遇》:对学术医疗中心的影响。
Mt Sinai J Med. 2004 Oct;71(5):314-21.
7
Health equity integrated epilepsy care and research: A narrative review.健康公平综合癫痫护理与研究:叙事性综述。
Epilepsia. 2023 Nov;64(11):2878-2890. doi: 10.1111/epi.17728. Epub 2023 Sep 19.
8
Racial-ethnic disparities in stroke care: the American experience: a statement for healthcare professionals from the American Heart Association/American Stroke Association.种族和民族差异在卒中护理中的表现:美国经验:美国心脏协会/美国卒中协会向医疗保健专业人员的声明。
Stroke. 2011 Jul;42(7):2091-116. doi: 10.1161/STR.0b013e3182213e24. Epub 2011 May 26.
9
The role of race and ethnicity in the State Children's Health Insurance Program (SCHIP) in four states: are there baseline disparities, and what do they mean for SCHIP?种族和族裔在四个州的儿童健康保险计划(SCHIP)中的作用:是否存在基线差异,以及这些差异对儿童健康保险计划意味着什么?
Pediatrics. 2003 Dec;112(6 Pt 2):e521.
10
The Intersection of Rural Residence and Minority Race/Ethnicity in Cancer Disparities in the United States.美国农村居住与癌症差异中的少数民族种族/族裔的交集。
Int J Environ Res Public Health. 2021 Feb 3;18(4):1384. doi: 10.3390/ijerph18041384.

引用本文的文献

1
A Patient Charter to Improve Care for Hepatocellular Carcinoma.改善肝细胞癌护理的患者宪章。
J Hepatocell Carcinoma. 2025 Aug 20;12:1849-1859. doi: 10.2147/JHC.S526170. eCollection 2025.
2
Trends in Incidence of Hepatocellular Carcinoma Between 2000 and 2020: A Surveillance, Epidemiology, and End Results (SEER)-Based Analysis.2000年至2020年间肝细胞癌发病率的趋势:一项基于监测、流行病学和最终结果(SEER)的分析。
Cureus. 2025 May 20;17(5):e84487. doi: 10.7759/cureus.84487. eCollection 2025 May.
3
Rising Incidence of Early-Onset Liver Cancer and Intrahepatic Bile Duct Cancer: Analysis of the National Childhood Cancer Registry Database.
早发性肝癌和肝内胆管癌发病率上升:国家儿童癌症登记数据库分析
Cancers (Basel). 2025 Mar 28;17(7):1133. doi: 10.3390/cancers17071133.
4
Social Determinants of Health Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease Prevalence and Severity: A Systematic Review and Meta-Analysis.与代谢功能障碍相关脂肪性肝病患病率及严重程度相关的健康社会决定因素:一项系统评价和荟萃分析
Am J Gastroenterol. 2025 Mar 17. doi: 10.14309/ajg.0000000000003421.
5
Adapting the NIMHD Research Framework for Type 2 Diabetes-Related Disparities.调整美国国立医学研究院少数族裔健康与健康不平等研究所(NIMHD)针对2型糖尿病相关差异的研究框架。
Curr Diab Rep. 2025 Mar 6;25(1):24. doi: 10.1007/s11892-025-01580-8.
6
The causal relationship between hepatitis B, immunophenotypes and liver cancer: a Mendelian randomization study.乙肝、免疫表型与肝癌之间的因果关系:一项孟德尔随机化研究。
Discov Oncol. 2025 Mar 5;16(1):266. doi: 10.1007/s12672-025-02023-2.
7
Persisting challenges in the early detection of hepatocellular carcinoma.肝细胞癌早期检测中持续存在的挑战。
Expert Rev Anticancer Ther. 2025 Feb 24:1-12. doi: 10.1080/14737140.2025.2467184.
8
Exploring social determinants and hepatocellular carcinoma: a scoping review of evidence and implications.探索社会决定因素与肝细胞癌:证据及影响的范围综述
Proc (Bayl Univ Med Cent). 2024 Oct 17;38(1):53-60. doi: 10.1080/08998280.2024.2406030. eCollection 2025.
9
Significant Disparities in Hepatocellular Carcinoma Outcomes by Race/Ethnicity and Sociodemographic Factors.肝细胞癌结局在种族/民族和社会人口学因素方面存在显著差异。
Cancer Epidemiol Biomarkers Prev. 2025 Feb 6;34(2):355-365. doi: 10.1158/1055-9965.EPI-24-1094.
10
The Influence of Residential Segregation, Urbanicity, and Population Density on Hepatocellular Carcinoma Incidence among a Low Socioeconomic Population.居住隔离、城市化程度和人口密度对低社会经济人群肝细胞癌发病率的影响
Cancer Epidemiol Biomarkers Prev. 2025 Feb 6;34(2):348-354. doi: 10.1158/1055-9965.EPI-24-1119.